Cryptolepis Synergy

by Return Healthy · capsule · 120 vegetarian capsules

  • On the market (NIH)
  • UPC 7 87790 57851 2
  • DSLD label 313309
  • Serving 2 capsules; amounts per 4 capsules
  • 30 servings

Cryptolepis Synergy by Return Healthy lists 8 ingredients, 8 with an amount per serving of 4 capsules, such as 250 mg of alchornea cordifolia, 250 mg of sida acuta, 250 mg of bidens pilosa and 125 mg of salvia miltiorrhiza. Its current label entered the NIH Dietary Supplement Label Database on July 25, 2024.

What is in Cryptolepis Synergy?

Each row as the label prints it, per serving of 4 capsules. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

Cryptolepis Synergy: Supplement Facts rows against the market (DSLD label 313309, January 2026 release)
IngredientAmount% DVAmong products listing it
Cryptolepis sanguinolenta750 mg
Alchornea cordifolia250 mg
Sida acuta250 mg
Bidens pilosa250 mg
Salvia miltiorrhiza125 mgRed-Rooted Sage in Cryptolepis Synergy against 36 products125 mg per serving; the middle half of products list 86.25 mg to 730 mg, the median 175 mg.125 mg

64% of 36 products listing red-rooted sage give more (median 175 mg). Per day at the most servings: 250 mg.

Ceanothus americanus125 mg
Eupatorium Perfolatum125 mg
Chenopodium ambrosioides125 mg
Copaiba Balsam Essential Oil20 mg

Source: NIH ODS Dietary Supplement Label Database, label 313309 (entered July 25, 2024), version 9.4.0. See the label on DSLD or its label image (PDF). Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

Every amount on this label with a position sits within the middle 80% of the products that list the same ingredient.

The NIH database records 2 servings a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
Directions: Take 2 capsules 2 times a day, or as directed by your health care practitioner, as a dietary supplement. Can be taken with or without food.
Warnings
Caution: Individuals who are pregnant or lactating should consult with their health care practitioner before using this product.
Do not use if security seal is broken or missing.
Keep out of reach of children.
Storage
Store in a cool dry place away from direct light.

Source: label statements in DSLD label 313309.

What else is on the label?

Other ingredients: Cellulose, Rice Concentrate.

How many labels does Cryptolepis Synergy have?

2 labels are on file under this name since January 23, 2023: other sizes, label designs and reformulations. The current one leads this page.

  1. Label 313309 (current) Entered July 25, 2024 · on the market · 120 vegetarian capsules · UPC 7 87790 57851 2
  2. Label 282157 Entered January 23, 2023 · off the market July 21, 2023 · 120 vegetarian capsules · UPC 7 87790 57851 2

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names Return Healthy LLC (distributor), St. George, UT. All Return Healthy products.

Where next?